Sven Roβwag

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Amplification and/or overexpression of the human epidermal growth factor 2 (HER2) oncogene occurs in about 13-15% of invasive breast cancer and triggers breast cancer cell proliferation, survival and metastatic progression. Around half of all breast cancers with HER2 overexpression co-express hormone receptors (HR) such as those for estrogen and(More)
  • 1